KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Other Working Capital Changes (2017 - 2025)

Bionano Genomics' Other Working Capital Changes history spans 7 years, with the latest figure at -$947000.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 219.87% year-over-year to -$947000.0; the TTM value through Sep 2025 reached -$5.3 million, down 2928.98%, while the annual FY2024 figure was -$4.7 million, 285.66% down from the prior year.
  • Other Working Capital Changes for Q3 2025 was -$947000.0 at Bionano Genomics, down from $29000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $3.7 million in Q3 2022 and bottomed at -$4.3 million in Q4 2024.
  • The 5-year median for Other Working Capital Changes is -$74000.0 (2025), against an average of -$124315.8.
  • The largest annual shift saw Other Working Capital Changes soared 2079.25% in 2021 before it crashed 2761.96% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$748000.0 in 2021, then surged by 74.6% to -$190000.0 in 2022, then skyrocketed by 185.79% to $163000.0 in 2023, then plummeted by 2761.96% to -$4.3 million in 2024, then soared by 78.17% to -$947000.0 in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Other Working Capital Changes are -$947000.0 (Q3 2025), $29000.0 (Q2 2025), and -$74000.0 (Q1 2025).